A world-leader in GPCR medicine design and development
Location: United Kingdom
Employees: 11-50
Investors 1
| Date | Name | Website |
| - | Omega Fund... | omegafunds... |
Mentions in press and media 2
| Date | Title | Description |
| 23.02.2015 | Sosei Acquires Heptares Therapeutics for up to $400M | Sosei Group Corporation (TOKYO:4565), a Japanese biopharmaceutical company with operations in Japan and the UK, acquired Heptares Therapeutics Limited, a UK-based clinical-stage biotechnology company focused on creating novel medicines targ... |
| 20.07.2005 | Sosei to acquire Arakis for 106.5 million | Sosei to acquire Arakis for 106.5 million 20-07-2005 Sosei Co. Ltd ('Sosei' - 4565, Tokyo Stock Exchange MOTHERS index), a leading Japanese biopharmaceutical company with operations in Japan and the UK, announces that it has agreed terms wi... |